DK0970106T3 - uPAR-imiterende peptider - Google Patents

uPAR-imiterende peptider

Info

Publication number
DK0970106T3
DK0970106T3 DK98916982T DK98916982T DK0970106T3 DK 0970106 T3 DK0970106 T3 DK 0970106T3 DK 98916982 T DK98916982 T DK 98916982T DK 98916982 T DK98916982 T DK 98916982T DK 0970106 T3 DK0970106 T3 DK 0970106T3
Authority
DK
Denmark
Prior art keywords
upar
peptides
useful
mimicking peptides
diseases
Prior art date
Application number
DK98916982T
Other languages
English (en)
Inventor
Francesco Blasi
Francesca Fazioli
Massimo Resnati
Sidenius Nicolai
Original Assignee
San Raffaele Centro Fond
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Raffaele Centro Fond, Univ Degli Studi Milano filed Critical San Raffaele Centro Fond
Application granted granted Critical
Publication of DK0970106T3 publication Critical patent/DK0970106T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK98916982T 1997-03-20 1998-03-18 uPAR-imiterende peptider DK0970106T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4111297P 1997-03-20 1997-03-20
EP98916982A EP0970106B1 (en) 1997-03-20 1998-03-18 uPAR-MIMICKING PEPTIDES
PCT/EP1998/001547 WO1998042733A1 (en) 1997-03-20 1998-03-18 uPAR MIMICKING PEPTIDE

Publications (1)

Publication Number Publication Date
DK0970106T3 true DK0970106T3 (da) 2005-01-10

Family

ID=21914807

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98916982T DK0970106T3 (da) 1997-03-20 1998-03-18 uPAR-imiterende peptider

Country Status (9)

Country Link
US (1) US6462170B1 (da)
EP (1) EP0970106B1 (da)
AT (1) ATE276268T1 (da)
AU (1) AU7036398A (da)
CA (1) CA2283637C (da)
DE (1) DE69826255T2 (da)
DK (1) DK0970106T3 (da)
ES (1) ES2224378T3 (da)
WO (1) WO1998042733A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129332A (en) * 1999-04-05 2006-12-10 Hadasit Med Res Service suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
EP1365797B1 (en) * 2001-01-25 2007-05-02 Fondazione Centro San Raffaele Del Monte Tabor Antibodies modulating the upa/upar interaction and uses thereof
EP2189469B1 (en) * 2004-11-18 2015-09-16 The Board Of Trustees Of The University Of Illinois Multicistronic siRNA constructs to inhibit tumors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1290267C (en) * 1985-04-15 1991-10-08 Lorin K. Johnson Human anti-inflammatory phospholipase inhibitor protein
WO1994028014A2 (en) * 1993-05-28 1994-12-08 Chiron Corporation Peptide inhibitors of urokinase receptor activity
WO1995007106A1 (en) * 1993-09-10 1995-03-16 The Regents Of The University Of California A method for identifying mutagenic agents using sperm from transgenic mice

Also Published As

Publication number Publication date
US6462170B1 (en) 2002-10-08
ES2224378T3 (es) 2005-03-01
DE69826255T2 (de) 2005-01-27
DE69826255D1 (de) 2004-10-21
WO1998042733A1 (en) 1998-10-01
AU7036398A (en) 1998-10-20
CA2283637A1 (en) 1998-10-01
CA2283637C (en) 2007-11-13
EP0970106A1 (en) 2000-01-12
EP0970106B1 (en) 2004-09-15
ATE276268T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
ATE397457T1 (de) Stimulierung von t-zellen gegen selbstantigene unter verwendung von ctla-4 inhibierenden wirkstoffen
NO20001600D0 (no) Apolipoprotein A-1-agonister og deres anvendelse for Õ behandle dyslipidemiske forstyrrelser
EP0998569A4 (en) POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN TRANSDUCED CELLS
DE69534878D1 (de) Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren
GR3033146T3 (en) Modified polypeptides with increased biological activity
FI892507L (fi) Terapeutiska peptider.
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
NO954722D0 (no) Peptid inhibitorer med urokinase reseptoraktivitet
ATE397062T1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
NZ515678A (en) Human GIL-19/AE289 proteins and polynucleotides encoding same
DE3885313D1 (de) Peptide mit Laminin-Wirksamkeit.
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
NO952385L (no) Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen
MY104909A (en) Peptide compounds.
ATE276268T1 (de) Upar-imitierende peptide
DE69725754D1 (de) Eingekapselte Antikörper-produzierende Zellen
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
PT782630E (pt) Gene da doenca poliquistica do rim
RU97103147A (ru) Днк-последовательности, кодирующие человеческие протеины тх и ту, родственные конвергирующему интерлейкин-1-бета ферменту
TR199902866T2 (xx) Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
DE3853743D1 (de) Rekombinanter menschlicher ADF.
MY127669A (en) Polypeptide hormone phosphatonin
BG105682A (en) Bone stimulating factor
FR2722209B1 (fr) Recepteur opioide kappa humain, acides nucleiques et utilisations
DE3869939D1 (de) Biologisch wirksame peptide.